Specialist R&D real estate investor has acquired Sycamore House from GSK to develop accommodation for commercial R&D businesses

We are delighted to have been accepted to join the London Knowledge Quarter as a partner

Creative Places client Kadans Science Partners has made its first acquisition in the UK R&D real estate market, acquiring the long leasehold interest in Building 900 at the Babraham Research Campus in Cambridge. 

Creative Places, in conjunction with Bidwells, has commissioned YouGov to survey the R&D heads of 50 large corporates to ask what they look for when make real estate decisions.

Creative Places has been recognised by the UK Science Park Association (UKSPA) for its work over a number of years in helping make Cambridge Biomedical Campus (CBC) one of the leading locations for Biomedical R&D in Europe.

Leading Life Sciences sector specialist joins award winning R&D property advisors, Creative Places.  Nykki Rogers joins the team to support the innovation and commercialisation agenda of university, science park and biomedical campus clients

Creative Places named Estates Gazette Specialist Advisor of the Year

Creative Places are delighted to announce that the specialist property advisor has been shortlisted for a prestigious national property award. 

Creative Places have undertaken a demand study for London on behalf of MedCity, funded by the London Enterprise Panel. 

Imperial College, Oxford University and Cambridge University retained their positions in the top ten global universities in the Times Higher Education rankings, published in May.

Global pharmaceutical giant AstraZeneca completed the acquisition of its site at Cambridge Biomedical Campus following grant of detailed planning permission for the first phase of its 80,000 sq. m. HQ and research facility.